iPierian

Acquired

Bristol Myers Squibb - Global Biopharmaceutical Company

iPierian was founded in 2008, is headquartered in South San Francisco, United States, lists 11–50 employees, and has 3 recorded funding rounds.

Employees
11–50
Founded
2008
Business Model
B2B
Last Round
Series CSep 2013
Rounds
3
Acquired by
Bristol-Myers Squibb CompanyApr 2014

Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.

About

iPierian (formerly iZumi Bio) was a South San Francisco biopharmaceutical company founded in 2008 that pioneered the use of induced pluripotent stem cell (iPSC) technology to model and develop therapies for neurodegenerative diseases, including ALS and tauopathies. The company was acquired by Bristol-Myers Squibb in 2014 for up to $725 million.

Summary

iPierian is a Biotech company based in South San Francisco, United States, founded in 2008. It lists 11–50 employees. Its most recent funding was a Series C round in Sep 2013. Investors include SR One, Kleiner Perkins and MPM Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionApr 2014

Sign up to see all 4 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

iPierian on Indexed.vc
<a href="https://indexed.vc/companies/ipierian"><img src="https://indexed.vc/api/badge/company/ipierian" alt="iPierian on Indexed.vc" width="260" height="76" /></a>